PPP2R5E expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.913600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.830810E-01
Normal-vs-Stage2
6.516400E-01
Normal-vs-Stage3
2.843800E-02
Normal-vs-Stage4
8.919000E-01
Stage1-vs-Stage2
4.682200E-01
Stage1-vs-Stage3
2.277800E-01
Stage1-vs-Stage4
2.651400E-01
Stage2-vs-Stage3
1.324010E-01
Stage2-vs-Stage4
4.733000E-01
Stage3-vs-Stage4
1.271240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.660600E-01
Normal-vs-AfricanAmerican
9.547600E-01
Normal-vs-Asian
3.601800E-01
Caucasian-vs-AfricanAmerican
5.140400E-01
Caucasian-vs-Asian
3.882400E-01
AfricanAmerican-vs-Asian
3.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.188600E-01
Normal-vs-Female
5.722400E-01
Male-vs-Female
9.891000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.910000E-01
Normal-vs-Age(41-60Yrs)
9.533400E-01
Normal-vs-Age(61-80Yrs)
4.456800E-01
Normal-vs-Age(81-100Yrs)
1.831150E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.337600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.545600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.857600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.883600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.614300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.161400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.687800E-01
Normal-vs-Daily Drinker
3.589800E-01
Normal-vs-Weekly Drinker
5.236400E-01
Normal-vs-Occasional Drinker
8.793400E-01
Normal-vs-Social Drinker
8.911200E-01
Non Drinker-vs-Daily Drinker
6.828800E-01
Non Drinker-vs-Weekly Drinker
6.275200E-01
Non Drinker-vs-Occasional Drinker
8.120200E-02
Non Drinker-vs-Social Drinker
1.424580E-01
Daily Drinker-vs-Weekly Drinker
5.109200E-01
Daily Drinker-vs-Occasional Drinker
1.019580E-01
Daily Drinker-vs-Social Drinker
1.613240E-01
Weekly Drinker-vs-Occasional Drinker
3.650800E-01
Weekly Drinker-vs-Social Drinker
4.578200E-01
Occasional Drinker-vs-Social Drinker
9.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.049800E-01
Normal-vs-Grade 2
1.422840E-01
Normal-vs-Grade 3
1.457980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.477200E-01
Grade 1-vs-Grade 3
8.805600E-02
Grade 1-vs-Grade 4
4.049800E-01
Grade 2-vs-Grade 3
2.198600E-01
Grade 2-vs-Grade 4
1.422840E-01
Grade 3-vs-Grade 4
1.457980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.564200E-01
Normal-vs-NonDiabetic
5.093600E-01
Diabetic-vs-NonDiabetic
7.392400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.233010E-01
Normal-vs-NoPancreatitis
5.638800E-01
Pancreatitis-vs-NoPancreatitis
1.953220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.502400E-01
Normal-vs-N1
6.828200E-01
N0-vs-N1
2.156800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.980400E-01
Normal-vs-TP53-NonMutant
5.777800E-01
TP53-Mutant-vs-TP53-NonMutant
2.888200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
